PKO Investment Management Joint-Stock Co
Position in ABT — Abbott Laboratories
CIK 2059321
WARSAW, R9
Position in ABT
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,905,540
-$404,535 QoQ
Shares Held
21,000
-6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,115
of 2,957 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $7,719,340 across 8 Medical Devices names. ABT ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
21,000 | $1,905,540 | |
| 2 | SYK |
Stryker Corp
|
5,000 | $1,574,200 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
21,000 | $1,344,210 | |
| 4 | DXCM |
Dexcom Inc
|
14,900 | $1,003,515 | |
| 5 | BSX |
Boston Scientific Corp
|
23,000 | $981,640 | |
| 6 | EW |
Edwards Lifesciences Corp
|
6,000 | $542,760 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
2,500 | $215,225 | |
| 8 | PODD |
Insulet Corp
|
1,000 | $152,250 |
All Filings in ABT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,905,540 | 21,000 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,310,075 | 22,500 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,006,960 | 24,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,231,696 | 39,060 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $5,040,530 | 37,060 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,387,700 | 18,000 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $1,922,870 | 17,000 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $1,482,130 | 13,000 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $2,182,110 | 21,000 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $1,704,900 | 15,000 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $1,871,190 | 17,000 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $1,937,000 | 20,000 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $2,289,420 | 21,000 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $2,126,460 | 21,000 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $1,921,325 | 17,500 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $2,031,960 | 21,000 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $2,607,600 | 24,000 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $3,787,520 | 32,000 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $2,814,800 | 20,000 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $1,255,131 | 10,625 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||